1 / 2

http://www.tenedonlineshop.com/athletic-greens/

FDA is investigating an increasing frequency of reports of serious and life-threatening blood clots and severe narrowing of blood vessels (arteries and veins) of patients taking the leukemia chemotherapy drug Iclusig (ponatinib). Data from clinical trials and postmarket adverse event reports show that serious adverse events have occurred in patients treated with Iclusig, including heart attacks resulting in death, worsening coronary artery disease, stroke, narrowing of large arteries of the brain, severe narrowing of blood vessels in the extremities, and the need for urgent surgical procedures to restore blood flow. FDA is actively working to further evaluate these adverse events and will notify the public when more information is available. <br><br>http://www.tenedonlineshop.com/athletic-greens/

Bennyphilips1
Download Presentation

http://www.tenedonlineshop.com/athletic-greens/

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Click Click Inclusig (Ponatin ib): Drug Safety Commun ication - Increase d thttp://www.tenedonline thttp://www.tenedonline shop.com/athletic- shop.com/athletic- greens/ greens/ Click to Edit Sub Title

More Related